Luma Group is a venture capital firm focused on science-driven biotechnology investing, combining scientific insight and computation to back companies translating breakthrough biology into therapies, diagnostics and medical devices. It invests in early and later-stage venture rounds, has acted as a co-lead investor in Series B financings, and focuses on life sciences sectors including biotechnology, pharmaceuticals, oncology, medical devices and AI-enabled approaches, with investment activity in Belgium and the United States.